Cancer Antigen-GI (CA 19-9)

0080461
copy
 

Copy Utility


emailprint
Example Reports
Abnormal
Normal

Ordering Recommendation

Mnemonic

CA-GI

Methodology

Quantitative Electrochemiluminescent Immunoassay

Performed

Sun-Sat

Reported

Within 24 hours

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation
Collect

Serum Separator Tube (SST) or Plasma Separator Tube (PST). Also acceptable: Green (lithium heparin), Lavender (K2EDTA or K3EDTA), or Pink (K2EDTA).

Specimen Preparation

Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Body Fluid (refer to Cancer Antigen-GI (CA19-9), Body Fluid, ARUP test code 0020746). Specimens collected in sodium citrate.

Remarks
Stability

After separation from cells: Ambient: 5 days; Refrigerated: 2 weeks; Frozen: 3 months

Reference Interval

Effective February 22, 2022
Less than or equal to 35 U/mL

Interpretive Data

This test uses Roche CA 19-9 electrochemiluminescent immunoassay. Results obtained with different test methods or kits cannot be used interchangeably. CA 19-9 is useful in monitoring pancreatic, hepatobiliary, gastric, hepatocellular, and colorectal cancer. CA 19-9 value regardless of level, should not be interpreted as absolute evidence of the presence or absence of malignant disease.  

Compliance Category

FDA

Note

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
02/22/2022
X
X
N/A

CPT Codes

86301

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
0080461 Cancer Antigen-GI (CA 19-9) 83084-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • CA 19-9
  • CA-GI
  • Cancer Antigen 19-9
  • Cancer Antigen-GI
  • Carbohydrate Antigen
  • Carbohydrate Antigen 19-9
  • GI Cancer Antigen
Cancer Antigen-GI (CA 19-9)